GSK

Also listed on its home exchange as GSK (LN), where funds report holdings that 13F filings leave out.

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Value held

$2.5bn

Combined value at quarter end

Last quarter

0 bought

4 sold or trimmed

Price at Q2 ’26 end

$52.42

-5.0% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+6.2%Q3 ’24

-17.3%Q4 ’24

+14.5%Q1 ’25

-0.9%Q2 ’25

+12.4%Q3 ’25

+13.6%Q4 ’25

+12.5%Q1 ’26

-5.0%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

4Q4 ’23

4Q1 ’24

4Q2 ’24

4Q3 ’24

4Q4 ’24

4Q1 ’25

4Q2 ’25

4Q3 ’25

4Q4 ’25

4Q1 ’26

4Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes GSK.

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Download the holders: CSV · JSON · Markdown

The same company’s shares listed in London, held in the full portfolios of US-registered funds (N-PORT). A 13F can’t show these. See the GSK page.

Funds holding GSK through GSK

Dodge & Cox International Stock FundDodge & Cox	2.5%	Trimmed -15%	$1.7bn
Dodge & Cox Global Stock FundDodge & Cox	1.5%	Trimmed -34%	$192m